Mycobacterium Avium Complex Clinical Trial
Official title:
A Randomized, Partially Blinded, Placebo- and Comparator-Controlled, Multicenter, Phase 2a, Dose Ranging, Proof-of-Concept Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of SPR720 as Compared With Placebo or Standard of Care for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
To evaluate the pharmacokinetics (PK) of SPR719, the active moiety, generated from the orally (po) administered SPR720 prodrug in a patient population with nontuberculous mycobacteria pulmonary disease (NTM-PD)
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05192057 -
Hypertonic Saline Inhalation for Mycobacterium Avium Complex Pulmonary Disease
|
Phase 4 | |
| Withdrawn |
NCT01719042 -
Improving Tolerance of Treatment of Pulmonary MAC Infections
|
Phase 2 | |
| Completed |
NCT00600769 -
Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
|
Phase 4 | |
| Recruiting |
NCT03236987 -
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections
|
Phase 3 | |
| Recruiting |
NCT04287049 -
A Study of Standard Drugs for Mycobacterium Avium Complex
|
Phase 2 | |
| Recruiting |
NCT03672630 -
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
|
Phase 2/Phase 3 | |
| Completed |
NCT04685720 -
A Pilot Study to Assess the Effect of Intermittent iNO on the Treatment of NTM Lung Infection in CF and Non-CF Patients
|
N/A | |
| Completed |
NCT00598962 -
Use of Azithromycin and Rifabutin Administered 3 Times Weekly for the Treatment of M. Avium Complex (MAC) Lung Disease
|
Phase 4 | |
| Recruiting |
NCT05824988 -
Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease
|
||
| Recruiting |
NCT02968212 -
Clofazimine in the Treatment of Pulmonary Mycobacterium Avium Complex (MAC)
|
Phase 2 |